[HTML][HTML] Aberrant B cell signaling in autoimmune diseases

OBJ Corneth, SFH Neys, RW Hendriks - Cells, 2022 - mdpi.com
Aberrant B cell signaling plays a critical in role in various systemic and organ-specific
autoimmune diseases. This is supported by genetic evidence by many functional studies in …

Assessment of disease activity and damage in SLE: Are we there yet?

C Cruciani, M Zen, M Gatto, E Morand… - Best Practice & Research …, 2023 - Elsevier
Abstract Systemic Lupus Erythematosus is a systemic autoimmune disease characterized by
a great heterogenicity in course and clinical manifestations. Although prognosis improved in …

[HTML][HTML] Белимумаб в лечении системной красной волчанки: 20 лет фундаментальных исследований, 10 лет клинической практики

ЕЛ Насонов, ТВ Попкова, АМ Лила - Научно-практическая …, 2021 - cyberleninka.ru
В настоящее время получены веские доказательства фундаментальной роли
патологической активации В-клеток в патогенезе иммуновоспалительных …

Translational implications of newly characterized pathogenic pathways in systemic lupus erythematosus

M Gatto, R Depascale, AL Stefanski… - Best Practice & …, 2023 - Elsevier
Improved characterization of relevant pathogenic pathways in systemic lupus erythematosus
(SLE) has been further delineated over the last decades. This led to the development of …

Recommendations for systemic lupus erythematosus: balancing evidence and eminence to facilitate the medical care of a complex disease

G Bertsias - Rheumatic Disease Clinics, 2022 - rheumatic.theclinics.com
Owing to its systemic nature with multiple organs potentially being affected concurrently or
sequentially and at varying degrees of severity, the management of systemic lupus …

Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren's syndrome: a literature review

R Depascale, G Del Frate… - Therapeutic …, 2021 - journals.sagepub.com
Lung involvement in systemic lupus erythematosus (SLE) and primary Sjögren's syndrome
(pSS) has extensively been outlined with a multiplicity of different manifestations. In SLE, the …

[HTML][HTML] Early and late response and glucocorticoid-sparing effect of Belimumab in patients with systemic lupus erythematosus with joint and skin manifestations …

M Zen, M Gatto, R Depascale, F Regola… - Journal of Personalized …, 2023 - mdpi.com
Aim. To assess the efficacy of belimumab in joint and skin manifestations in a nationwide
cohort of patients with SLE. Methods. All patients with skin and joint involvement enrolled in …

[PDF][PDF] Aberrant B Cell Signaling in Autoimmune Diseases. Cells 2022, 11, 3391

OBJ Corneth, SFH Neys, RW Hendriks - 2022 - pure.eur.nl
Aberrant B cell signaling plays a critical in role in various systemic and organ-specific
autoimmune diseases. This is supported by genetic evidence by many functional studies in …

[PDF][PDF] 贝利尤单抗治疗系统性红斑狼疮/狼疮性肾炎的快速卫生技术评估

雍素云, 刘晓玲, 朱亚宁, 王鹏翀, 张鹏… - Clinical Medication …, 2023 - lcywzlzz.com
目的快速评价贝利尤单抗治疗系统性红斑狼疮(SLE)/狼疮性肾炎(LN) 的安全性,
有效性和经济性, 为临床合理用药提供参考. 方法计算机检索Pubmed, Embase, the Cochrane …

贝利尤单抗联合环孢素治疗难治性系统性红斑狼疮继发免疫性血小板减少1 例并文献复习

秦梅杰, 田茂露, 杨宇齐, 查艳, 袁静 - 临床荟萃, 2022 - huicui.hebmu.edu.cn
目的探讨贝利尤单抗治疗难治性系统性红斑狼疮(systemic lupus erythematosus, SLE)
合并顽固性血液系统损害的疗效. 方法回顾性分析贵州省人民医院收治的1 例以顽固性血液系统 …